查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1609559

胰蛋白酶市場規模、佔有率、趨勢分析報告：按來源、按應用、按最終用途、按地區、按細分市場、預測，2025-2030 年

Trypsin Market Size, Share & Trends Analysis Report By Source (Bovine, Porcine), By Application (Biotechnology & Pharmaceutical Industry, Food Industry), By End-use (Research, Diagnostic, Industrial Use), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

胰蛋白酶市場成長與趨勢

Grand View Research, Inc.最新報告顯示，預計2030年全球胰蛋白酶市場規模將達1,315億美元，2025年至2030年複合年成長率為5.4%。

胰蛋白酶在製藥、食品科學研究、清潔劑和皮革加工等各個行業中的日益採用可能會推動市場成長。人們已經進行了各種研究來評估胰蛋白酶在診斷癌症、急性胰臟炎、吸收不良和囊腫纖維化等多種疾病方面的潛力，並且對藥物發現和研究與開發的日益關注預計將進一步推動。市場成長。

胰蛋白酶因其水解蛋白質的特殊消化功能而被廣泛應用於醫藥、食品、環保等產業的研發。胰蛋白酶作為內分泌疾病和臨床外科內科藥物的原料。酵素催化劑的使用正在擴大在製藥、食品和飲料以及食品工業的商業過程。這些酵素在食品、製藥和飼料行業中的使用非常高效，因為它們有助於減少廢棄物。此外，TRYPSIN VI 是胰蛋白酶的最佳來源，可用於營養食品，作為動物和人類的抗發炎治療和消化食品。

已經進行了各種研究來評估其診斷多種疾病的潛力，包括癌症、急性胰臟炎、吸收不良和囊腫纖維化。研發支出增加，新藥上市增加，FDA核准增加。

胰蛋白酶市場報告亮點

  • 從來源來看，由於其在臨床診斷、研究、食品和飲料行業以及肉類嫩化領域的突出應用，牛類細分市場在 2024 年以 59.71% 的最大收益佔有率引領市場。
  • 從來源來看，生豬市場預計在預測期內將以顯著的複合年成長率成長。
  • 從應用來看，生技和製藥產業細分市場將在2024年佔據最高收益佔有率，達到56.40%，預計在預測期內複合年成長率最快。對藥物發現和開發的日益關注進一步推動了成長。
  • 由於各種癌症盛行率增加、高購買力平價、政府對優質醫療保健的支持以及可報銷的可獲得性等因素，北美地區將在 2024 年以 40.49% 的最大收入佔有率成長。
  • 2023年12月，商務用酵素相關產品和服務的全球先驅Creative Enzymes推出了蛋白水解酶組合產品，包括胰蛋白酶-胰凝乳蛋白酶。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章胰蛋白酶市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/補充市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 胰蛋白酶市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章胰蛋白酶市場：依供應來源估算與趨勢分析

  • 世界胰蛋白酶：來源儀表板
  • 世界胰蛋白酶：2024 年和 2030 年來源變異分析
  • 2018-2030 年全球胰蛋白酶收益（按來源）
  • 2018-2030年市場規模、預測及趨勢分析
  • 豬
  • 牛
  • 其他

第5章胰蛋白酶市場：按應用、估計和趨勢分析

  • 世界各地的胰蛋白酶：應用儀​​表板
  • 全球胰蛋白酶：2024 年和 2030 年應用變化分析
  • 2018-2030年全球胰蛋白酶收益（按應用）
  • 2018-2030年市場規模、預測及趨勢分析
  • 生技/製藥業
  • 食品工業
  • 化妝品/個人護理
  • 廢棄物處理
  • 其他

第6章胰蛋白酶市場：最終用途的估計和趨勢分析

  • 世界各地的胰蛋白酶：最終用途儀表板
  • 全球胰蛋白酶：2024 年和 2030 年最終用途變化分析
  • 2018-2030 年全球胰蛋白酶收益（以最終用途）
  • 2018-2030年市場規模、預測及趨勢分析
  • 研究
  • 診斷
  • 工業用途

第7章胰蛋白酶市場：區域、估計與趨勢分析

  • 2024 年及 2030 年按地區分類的市場佔有率分析
  • 區域市場儀表板
  • 全球區域市場簡介
  • 2018-2030年市場規模、預測趨勢分析
  • 北美洲
    • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商及通路夥伴名單
    • 2024年主要企業市場佔有率分析
    • Thermo Fisher Scientific, Inc
    • Promega Corporation
    • Merck Millipore
    • Novozymes
    • Sartorius AG
    • Neova Technologies
    • BIOZYM
    • Bovogen Biologicals
    • Zymetech
    • BBI Solutions
    • Linzyme Biosciences
    • PromoCell GmbH
Product Code: GVR-4-68040-273-6

Trypsin Market Growth & Trends:

The global trypsin market size is estimated to reach USD 131.5 billion by 2030, registering a CAGR of 5.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The increasing adoption of trypsin across various industries, such as pharmaceuticals, food science research, detergents, and leather-bating, is likely to drive the market growth. Where as various research studies are being conducted to evaluate its potential in diagnosing a wide range of disorders, such as cancer, acute pancreatitis, malabsorption, and cystic fibrosis, along with increasing focus on drug discovery and development is expected to further propel the market growth.

Trypsin is widely being used in R&D in pharmaceutical, food, and environmental industries, owing to its special digestive functions of hydrolyzing proteins. It acts as a raw material for internal medicine in endocrine diseases and clinical surgery. The use of enzyme catalysts has been scaled up for commercial processes in the pharmaceutical, beverages, and food industries. These enzymes help in waste reduction, which makes them highly efficient to be used in food, pharmaceuticals, and feed industries. Moreover, the best source of trypsin, TRYPSIN VI, has found nutraceutical use as an anti-inflammatory treatment and a digestive supplement for veterinary & human applications.

Various research studies are being conducted to evaluate its potential in diagnosing a wide range of disorders, such as cancer, acute pancreatitis, malabsorption, and cystic fibrosis. Increase in R&D expenditure, the rising drug launches, and FDA approvals.

Trypsin Market Report Highlights:

  • Based on source, the bovine segment led the market with the largest revenue share of 59.71% in 2024, owing to prominent application in field of clinical diagnostics, research, food and beverage industry and meat tenderization
  • Based on source, the porcine segment is expected to grow at the significant CAGR over the forecast period
  • Based on application, the biotechnology and pharmaceutical industry segment held the market with the largest revenue share of 56.40% in 2024, and is further anticipated to witness the fastest CAGR over the forecast period. The increasing focus on drug discovery and development is further propelling growth
  • North America dominated the market with the largest revenue share of 40.49% in 2024, owing to factors such as increasing the prevalence of various cancer, high purchasing power parity, government support for quality healthcare, and availability of reimbursement
  • In Dec 2023, Creative Enzymes, a global pioneer in professional enzyme related products and services unveiled its combination product offerings for proteolytic enzymes such as Trypsin-Chymotrypsin, with this company aims at optimizing the speed and efficiency of the digestive process opening new possibilities for medical and pharmaceutical enhancements.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1 Source
    • 1.2.2 Application
    • 1.2.3 end use
    • 1.2.4 Regional scope
    • 1.2.5 Estimates and forecasts timeline.
  • 1.3. Research methodology
  • 1.4. Information Procurement
    • 1.4.1 Purchased database
    • 1.4.2 GVR's internal database
    • 1.4.3 Secondary sources
    • 1.4.4 Primary research
    • 1.4.5 Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1 Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1 Commodity flow analysis (Model 1)
    • 1.7.2 Approach 1: Commodity flow approach
    • 1.7.3 Volume price analysis (Model 2)
    • 1.7.4 Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1 Source outlook
    • 2.2.2 Application outlook
    • 2.2.3 end use outlook
    • 2.2.4 Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Trypsin Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 1.3.1 Parent market outlook
    • 2.3.1 Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1 Market driver analysis
      • 3.2.1.1. Rising prevalence of gastrointestinal disorders
      • 3.2.1.2. Increasing trypsin related studies and therapeutics
      • 3.2.1.3. Technological advancements
    • 3.2.2 Market restraint analysis
      • 3.2.2.1. Stringent regulations
      • 3.2.2.2. High cost of sourcing
  • 3.3. Trypsin Market Analysis Tools
    • 3.3.1 Industry Analysis - Porter's
    • 3.3.1 PESTEL Analysis

Chapter 4. Trypsin Market: Source Estimates & Trend Analysis

  • 4.1. Global Trypsin: Source Dashboard
  • 4.2. Global Trypsin: Source Movement Analysis 2024 & 2030
  • 4.3. Global Trypsin by Source, Revenue 2018 - 2030 (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Porcine
    • 4.5.1 Porcine Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Bovine
    • 4.6.1 Bovine Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1 Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Trypsin Market: Application Estimates & Trend Analysis

  • 5.1. Global Trypsin: Application Dashboard
  • 5.2. Global Trypsin: Application Movement Analysis 2024 & 2030
  • 5.3. Global Trypsin by Application, Revenue 2018 - 2030 (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Biotechnology and Pharmaceutical Industry
    • 5.5.1 Biotechnology and Pharmaceutical Industry Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Food Industry
    • 5.6.1 Food Industry Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Cosmetics and Personal Care
    • 5.7.1 Cosmetics and Personal Care Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.8. Waste Treatment
    • 5.8.1 Waste Treatment Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.9. Others
    • 5.9.1 Others Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Trypsin Market: end use Estimates & Trend Analysis

  • 6.1. Global Trypsin: end use Dashboard
  • 6.2. Global Trypsin: end use Movement Analysis 2024 & 2030
  • 6.3. Global Trypsin by end use, Revenue 2018 - 2030 (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Research
    • 6.5.1 Research Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Diagnostics
    • 6.6.1 Diagnostics Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Industrial use
    • 6.7.1 Industrial use Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Trypsin Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1 North America
    • 7.5.2 U.S.
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3 Canada
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4 Mexico
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1 Europe
    • 7.6.2 UK
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3 Germany
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4 France
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5 Italy
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6 Spain
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7 Norway
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8 Sweden
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.9 Denmark
      • 7.6.9.1. Key country dynamics
      • 7.6.9.2. Regulatory framework
      • 7.6.9.3. Competitive scenario
      • 7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1 Asia Pacific
    • 7.7.2 Japan
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3 China
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4 India
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5 Australia
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6 South Korea
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.7 Thailand
      • 7.7.7.1. Key country dynamics
      • 7.7.7.2. Regulatory framework
      • 7.7.7.3. Competitive scenario
      • 7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1 Latin America
    • 7.8.2 Brazil
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3 Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1 MEA
    • 7.9.2 South Africa
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3 Saudi Arabia
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4 UAE
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.5 Kuwait
      • 7.9.5.1. Key country dynamics
      • 7.9.5.2. Regulatory framework
      • 7.9.5.3. Competitive scenario
      • 7.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1 List of key distributors and channel partners
    • 8.3.2 Key customers
    • 8.3.3 Key company market share analysis, 2024
    • 8.3.4 Thermo Fisher Scientific, Inc
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Source benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5 Promega Corporation
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Source benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6 Merck Millipore
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Source benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7 Novozymes
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Source benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8 Sartorius AG
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Source benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Neova Technologies
      • 8.3.9.6. Company overview
      • 8.3.9.7. Financial performance
      • 8.3.9.8. Source benchmarking
      • 8.3.9.9. Strategic initiatives
    • 8.3.10 BIOZYM
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Source benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11 Bovogen Biologicals
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Source benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12 Zymetech
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Source benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13 BBI Solutions
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Source benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14 Linzyme Biosciences
      • 8.3.14.1. Company Overview
      • 8.3.14.2. Financial Performance
      • 8.3.14.3. Source Benchmarking
      • 8.3.14.4. Strategic Initiatives
    • 8.3.15 PromoCell GmbH.
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial Performance
      • 8.3.15.3. Source Benchmarking
      • 8.3.15.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America Trypsin market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 4 North America Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S. Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 7 U.S. Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 10 Canada Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 13 Mexico Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 14 Mexico Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe Trypsin market, by region, 2018 - 2030 (USD Million)
  • Table 16 Europe Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 17 Europe Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Germany Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 20 Germany Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 21 Germany Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 22 UK Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 23 UK Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 24 UK Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 25 France Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 26 France Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 27 France Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Italy Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 29 Italy Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 30 Italy Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Spain Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 32 Spain Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 33 Spain Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Denmark Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 35 Denmark Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 36 Denmark Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Sweden Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 38 Sweden Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 39 Sweden Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Norway Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 41 Norway Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 42 Norway Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific Trypsin market, by region, 2018 - 2030 (USD Million)
  • Table 44 Asia Pacific Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 45 Asia Pacific Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 48 China Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 49 China Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 50 Japan Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 51 Japan Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 52 Japan Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 53 India Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 54 India Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 55 India Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Korea Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 57 South Korea Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 59 Australia Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 60 Australia Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Thailand Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 63 Thailand Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 64 Thailand Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 66 Latin America Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 67 Latin America Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 68 Brazil Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 69 Brazil Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 70 Brazil Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 71 Argentina Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 72 Argentina Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 73 Argentina Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 74 MEA Trypsin market, by region, 2018 - 2030 (USD Million)
  • Table 75 MEA Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 76 MEA Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 77 MEA Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 78 South Africa Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 79 South Africa Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 80 South Africa Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 84 UAE Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 85 UAE Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 86 UAE Trypsin market, by end use, 2018 - 2030 (USD Million)
  • Table 87 Kuwait Trypsin market, by source, 2018 - 2030 (USD Million)
  • Table 88 Kuwait Trypsin market, by application, 2018 - 2030 (USD Million)
  • Table 89 Kuwait Trypsin market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Trypsin market: market outlook
  • Fig. 14 Trypsin competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook.
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Trypsin market driver impact
  • Fig. 20 Trypsin market restraint impact
  • Fig. 21 Trypsin market strategic initiatives analysis
  • Fig. 22 Trypsin market: Source movement analysis
  • Fig. 23 Trypsin market: Source outlook and key takeaways
  • Fig. 24 Bovine market estimates and forecasts, 2018 - 2030
  • Fig. 25 Porcine market estimates and forecasts,2018 - 2030
  • Fig. 26 Others market estimates and forecasts,2018 - 2030
  • Fig. 27 Trypsin market: Application movement analysis
  • Fig. 28 Trypsin market: Application outlook and key takeaways
  • Fig. 29 Biotechnology and Pharmaceutical Industry market estimates and forecast, 2018 - 2030
  • Fig. 30 Food Industry market estimates and forecast, 2018 - 2030
  • Fig. 31 Cosmetics and Personal Care market estimates and forecast, 2018 - 2030
  • Fig. 32 Waste Treatment market estimates and forecast, 2018 - 2030
  • Fig. 33 Others market estimates and forecast, 2018 - 2030
  • Fig. 34 Trypsin market: end use movement analysis
  • Fig. 35 Trypsin market: end use outlook and key takeaways
  • Fig. 36 Research Studies market estimates and forecasts, 2018 - 2030
  • Fig. 37 Diagnostics market estimates and forecasts,2018 - 2030
  • Fig. 38 Industrial use market estimates and forecasts, 2018 - 2030
  • Fig. 39 Global Trypsin market: Regional movement analysis
  • Fig. 40 North America market estimates and forecasts, 2018 - 2030
  • Fig. 41 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 42 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 43 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 44 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 45 UK market estimates and forecasts, 2018 - 2030
  • Fig. 46 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 47 France market estimates and forecasts, 2018 - 2030
  • Fig. 48 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 49 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 50 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 51 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 52 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 53 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 54 China market estimates and forecasts, 2018 - 2030
  • Fig. 55 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 56 India market estimates and forecasts, 2018 - 2030
  • Fig. 57 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 58 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 59 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 60 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 61 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 62 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 63 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 64 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 65 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 66 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 67 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 68 Market share of key market players - Trypsin market